Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neuraxis (NRXS) Other Accumulated Expenses (2022 - 2025)

Neuraxis' Other Accumulated Expenses history spans 4 years, with the latest figure at $37770.0 for Q3 2025.

  • For Q3 2025, Other Accumulated Expenses fell 33.02% year-over-year to $37770.0; the TTM value through Sep 2025 reached $37770.0, down 33.02%, while the annual FY2024 figure was $29174.0, 2929.49% up from the prior year.
  • Other Accumulated Expenses for Q3 2025 was $37770.0 at Neuraxis, down from $63996.0 in the prior quarter.
  • Across five years, Other Accumulated Expenses topped out at $155351.0 in Q1 2025 and bottomed at $963.0 in Q4 2023.
  • The 4-year median for Other Accumulated Expenses is $37770.0 (2025), against an average of $45780.7.
  • The largest annual shift saw Other Accumulated Expenses plummeted 97.12% in 2023 before it soared 4267.7% in 2024.
  • A 4-year view of Other Accumulated Expenses shows it stood at $33395.0 in 2022, then tumbled by 97.12% to $963.0 in 2023, then surged by 2929.49% to $29174.0 in 2024, then grew by 29.46% to $37770.0 in 2025.
  • Per Business Quant, the three most recent readings for NRXS's Other Accumulated Expenses are $37770.0 (Q3 2025), $63996.0 (Q2 2025), and $155351.0 (Q1 2025).